Adaptimmune Therapeutics Plc ADR (ADAP) Stock: Navigating a Year of Stock Volatility

THMO

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Adaptimmune Therapeutics Plc ADR’s current trading price is -94.13% away from its 52-week high, while its distance from the 52-week low is 5.69%. The stock’s price range during this period has varied between $0.08 and $1.36. The company, active in the Healthcare sector, saw a trading volume of around 82.87 million for the day, considerably higher average daily volume of 5.26 million observed over the last three months.

Currently, the stock price of Adaptimmune Therapeutics Plc ADR (ADAP) is $0.08. In the most recent trading session, the stock underwent a significant upswing, peaking at $1.5 after opening at $0.08. The stock touched a low of $0.11 before closing at $0.08.

Adaptimmune Therapeutics Plc ADR’s stock has seen a rocky market performance.

How Financial Performance Impacts Market Capitalization

Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly decline of -70.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.60M and boasts a workforce of 506 employees.

Decoding Analysts’ Ratings for Adaptimmune Therapeutics Plc ADR

As of right now, 0 analyst is rating Adaptimmune Therapeutics Plc ADR as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2707, with a change in price of -0.3702. Similarly, Adaptimmune Therapeutics Plc ADR recorded 4,937,732 in trading volume during the last 100 days, posting a change of -82.25%.

ADAP Stock Stochastic Average

As of today, the raw stochastic average of Adaptimmune Therapeutics Plc ADR over the past 50 days is 1.52%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 1.52%. Additionally, the Stochastic %K and %D values for the company were 1.33% and 1.55%, respectively, over the past 20 days.

ADAP Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -93.85%. However, over the past six months, we’ve seen a stronger performance of -86.88%. The price of ADAP leaped by -67.04% over the last 30 days. And in the last five days, it has fallen by -76.97%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.